Intellus Advisors’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Intellus Advisors's JNJ Position: Q2 2026 in Review
Intellus Advisors reduced its Johnson & Johnson (JNJ) stake by 1.1% in Q2 2026, selling an estimated $9.32K and leaving 3,644 shares worth $925K. The position accounts for 0.11% of the portfolio, ranked #54.
Intellus Advisors first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Intellus Advisors held 3,644 shares of Johnson & Johnson worth $925K as of Q2 2026.
- Intellus Advisors sold 40 Johnson & Johnson shares in Q2 2026, an estimated $9.32K.
- Johnson & Johnson made up 0.11% of Intellus Advisors's portfolio in Q2 2026, its #54 holding.
- Intellus Advisors first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
- 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Intellus Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.